Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Imprimis Pharmaceuticals, Inc. (IMMY)

« Back to company index

IMMY Chatter Timeline

Stock Ticker for IMMY

Most Active Tweeters for IMMY

UserTweets
@Stock_News_Now 2
@WatchlistN 1
@StockTexts 1
@ConsumerFeed 1
@bulletin_en 1

Recent Tweets for IMMY

EricaT513 @EricaT513
Yung $immy lives on ?? @ Over-The-Rhine, Ohio https://t.co/O8Kyg8LdFa
March 21st 2019, 12:03pm
ConsumerFeed @ConsumerFeed
Imprimis Pharmaceuticals $IMMY vs. Vernalis $VNLPY Head-To-Head Review https://t.co/vEZMkpNJM8
March 20th 2019, 1:03pm
Stock_News_Now @Stock_News_Now
$IMMY: New SEC Filing for IMMY: Form 8-K (No. 0001493152-19-003523): https://t.co/krIAbO2UO1
March 18th 2019, 8:03am
StockTexts @StockTexts
$IMMY Imprimis Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/HcghnlDphA
March 18th 2019, 8:03am
WatchlistN @WatchlistN
Head-To-Head Review: Imprimis Pharmaceuticals $IMMY vs. Vernalis $VNLPY https://t.co/lzyq62SFrw
March 18th 2019, 3:03am
AmericanBanking @AmericanBanking
Vernalis $VNLPY & Imprimis Pharmaceuticals $IMMY Head-To-Head Comparison https://t.co/qNvNnjHKow #stocks
March 15th 2019, 2:03am
Stock_News_Now @Stock_News_Now
$IMMY: New SEC Filing for IMMY: Form 10-K (No. 0001493152-19-003188): https://t.co/2wnX7mEL2B
March 12th 2019, 4:03pm
bibeypost_stock @bibeypost_stock
2018 Q4 Sentiment Imprimis Pharmaceuticals Inc $IMMY https://t.co/atzKiTb3W6
March 10th 2019, 11:03am
bulletin_en @bulletin_en
Imprimis Pharmaceuticals Inc $IMMY: Negative Stock Sentiment at 1.92 https://t.co/1ej7tsV7PW
March 9th 2019, 8:03am
StockTexts @StockTexts
$IMMY Imprimis Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/PSiNfr7QmY
March 4th 2019, 6:03pm
Stock_News_Now @Stock_News_Now
$IMMY: New SEC Filing for IMMY: Form 8-K (No. 0001493152-19-002803): https://t.co/DjYeEm42nD
March 4th 2019, 7:03am
StockTexts @StockTexts
$IMMY Imprimis Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/Z4LMWJIiH4
March 4th 2019, 7:03am
thefinreviewer @thefinreviewer
Exelixis Inc. $IMMY Comparing side by side https://t.co/7KWSpNuVEZ
March 1st 2019, 11:03pm
bibeypost_stock @bibeypost_stock
Imprimis Pharmaceuticals Inc $IMMY: Institutional Investor Sentiment Up to 6.5 https://t.co/6pwbXTQTIN
March 1st 2019, 9:03am
thefinreviewer @thefinreviewer
Anika Therapeutics Inc. $IMMY Comparing side by side https://t.co/05owHkL6YG
February 27th 2019, 7:02am
Stock_News_Now @Stock_News_Now
$IMMY: New SEC Filing for IMMY: Form 8-K (No. 0001493152-19-002482): https://t.co/61XQbg5MwQ
February 25th 2019, 8:02am
StockTexts @StockTexts
$IMMY Imprimis Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/fMTcHcPVYk
February 25th 2019, 8:02am
confcalltran @confcalltran
Departure of Directors or Certain https://t.co/pG21esWU2Z $IMMY
February 25th 2019, 8:02am
whatsonthorold2 @whatsonthorold2
Institutional Investors Are Buying Imprimis Pharmaceuticals Inc $IMMY https://t.co/UrtspFiqOu
February 24th 2019, 8:02am
thefinreviewer @thefinreviewer
Adial Pharmaceuticals Inc. $IMMY Comparison side by side https://t.co/8XWxjZHHlI
February 23rd 2019, 8:02pm
reurope_stock @reurope_stock
Is Imprimis Pharmaceuticals Inc $IMMY’s Fuel Running High? Reports Show Less Sellers https://t.co/XzYxId2K8E
February 22nd 2019, 4:02pm
thefinreviewer @thefinreviewer
Reviewing Akari Therapeutics Plc $IMMY's results https://t.co/3PqgXYzSqD
February 21st 2019, 8:02pm
confcalltran @confcalltran
Imprimis Pharmaceuticals, Inc.'s Chief Executive Officer was just granted 150,000 options https://t.co/0oN2bkyeLw $IMMY
February 21st 2019, 8:02pm
confcalltran @confcalltran
Imprimis Pharmaceuticals, Inc.'s Chief Financial Officer was just granted 100,000 options and r https://t.co/GsXip2EJIU $IMMY
February 21st 2019, 8:02pm
confcalltran @confcalltran
Imprimis Pharmaceuticals, Inc.'s Chief Commercial Officer was just granted 100,000 options and https://t.co/M4z3GNwlDd $IMMY
February 21st 2019, 8:02pm
StockTexts @StockTexts
$IMMY Imprimis Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/arWf2wLn7n
February 21st 2019, 7:02pm
mmahotstuff1 @mmahotstuff1
Do Institutional Investors Love Imprimis Pharmaceuticals Inc $IMMY? https://t.co/fsk3N8vGE5
February 19th 2019, 8:02am
bulletin_en @bulletin_en
Contrasting of Editas Medicine Inc. $IMMY https://t.co/NcrozX5bHL
February 19th 2019, 2:02am
thefinreviewer @thefinreviewer
Loxo Oncology Inc. $IMMY https://t.co/8hUWjVXXYf
February 18th 2019, 6:02pm
confcalltran @confcalltran
Statement of acquisition of beneficial ownership by individuals https://t.co/WMkniaJS10 $IMMY
February 14th 2019, 6:02pm
mmahotstuff1 @mmahotstuff1
Imprimis Pharmaceuticals Inc $IMMY Sentiment Up, Despite https://t.co/A3lPxJTdpD
February 14th 2019, 9:02am
whatsonthorold2 @whatsonthorold2
Imprimis Pharmaceuticals Inc $IMMY Sentiment Increased, Because https://t.co/wIK7F00KVI
February 14th 2019, 9:02am
mmahotstuff1 @mmahotstuff1
Time to Reconsider Imprimis Pharmaceuticals Inc $IMMY After Less Short Sellers? https://t.co/gwgmWyL5p8
February 14th 2019, 6:02am
whatsonthorold2 @whatsonthorold2
Imprimis Pharmaceuticals Inc $IMMY Could Improve Your Long Portfolio After Less Shorts Reported https://t.co/GcMK8Xw4Tw
February 14th 2019, 6:02am
bibeypost_stock @bibeypost_stock
Imprimis Pharmaceuticals Inc $IMMY Just Reported Decreased Shorts https://t.co/uWCX7kgX7f
February 14th 2019, 6:02am
reurope_stock @reurope_stock
Could Imprimis Pharmaceuticals Inc $IMMY See a Reversal After Less Sellers Came In? https://t.co/sqS8uJuHBC
February 14th 2019, 6:02am
thefinreviewer @thefinreviewer
Reviewing Imprimis Pharmaceuticals Inc. $IMMY's and Its Rivals results https://t.co/9aaO3kzZqw
February 13th 2019, 9:02am
yvsx @yvsx
$HROW is the old $IMMY https://t.co/JGp5Qgsbst. https://t.co/8znzTowrFy
February 11th 2019, 10:02am
yvsx @yvsx
$HROW old $IMMY https://t.co/K9EbdFWHI1 https://t.co/HZp2KCONzJ https://t.co/RY8NAkViZM
February 11th 2019, 9:02am
Stock_News_Now @Stock_News_Now
$IMMY: New SEC Filing for IMMY: Form 8-K (No. 0001493152-19-001547): https://t.co/t3WSXE5SKh
February 7th 2019, 4:02pm
StockTexts @StockTexts
$IMMY Imprimis Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/q7kVabZU8i
February 7th 2019, 4:02pm
Stock_News_Now @Stock_News_Now
$IMMY: New SEC Filing for IMMY: Form 8-K (No. 0001493152-19-001358): https://t.co/HfeNz4weUB
February 5th 2019, 7:02am
StockTexts @StockTexts
$IMMY Imprimis Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/R6Q1mOk8uy
February 5th 2019, 7:02am
mmahotstuff1 @mmahotstuff1
Does Imprimis Pharmaceuticals Inc $IMMY Have Gas After Even Less Sellers Involved? https://t.co/g41LEWv8S5
January 23rd 2019, 10:01am
reurope_stock @reurope_stock
Can Imprimis Pharmaceuticals Inc $IMMY’s Tomorrow Be Different? The Stock Had Decline in Shorts https://t.co/KD7tGExmjL
January 23rd 2019, 10:01am
reurope_stock @reurope_stock
Imprimis Pharmaceuticals Inc $IMMY: Positive Stock Sentiment https://t.co/r6Er2EFFqK
January 23rd 2019, 7:01am
mmahotstuff1 @mmahotstuff1
Imprimis Pharmaceuticals Inc $IMMY Has Decline in Shorts https://t.co/ddx09vcJUN
January 17th 2019, 6:01am
whatsonthorold2 @whatsonthorold2
Imprimis Pharmaceuticals Inc $IMMY Shorts Decreased by 38.13% After Short Covering https://t.co/cDiE78QxCX
January 17th 2019, 6:01am
bibeypost_stock @bibeypost_stock
What's Imprimis Pharmaceuticals Inc $IMMY Upside After This Short Interest Decrease? https://t.co/6KpHei7ZZn
January 17th 2019, 6:01am
reurope_stock @reurope_stock
Imprimis Pharmaceuticals Inc $IMMY Short Interest Decreased By 38.13% https://t.co/EgQ1FWRoWN
January 17th 2019, 6:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.